Liver Disease in Dogs: Comprehensive Welfare Guide

Key Welfare Considerations

• The liver's central metabolic role means hepatic disease affects virtually all body systems with welfare implications.
• Hepatic encephalopathy from liver failure causes neurological welfare signs including circling, seizures, and confusion.
• Portosystemic shunts in young dogs cause welfare neurological signs from ammonia accumulation.
• Copper storage hepatopathy in Bedlington Terriers, West Highland Whites, and Labradors causes chronic welfare liver damage.
• Breed-specific copper hepatopathy testing and low-copper diet management improves welfare prognosis.
• Chronic active hepatitis causes progressive welfare liver damage requiring immunosuppressive management.
• Phenobarbitol and other anticonvulsant-induced hepatopathy requires monitoring and welfare dose adjustment.
• Xylitol, paracetamol, and other hepatotoxins cause acute welfare liver failure in dogs.
• Leptospirosis hepatic disease welfare requires rapid antibiotic treatment alongside supportive care.
• Liver enzymes (ALT, ALP, GGT) are welfare indicators but liver biopsy confirms diagnosis for treatment decisions.
• S-adenosyl methionine (SAMe) and milk thistle (silymarin) provide antioxidant welfare hepatic support.
• Ursodeoxycholic acid improves bile flow and provides welfare anti-inflammatory benefit in chronic hepatopathy.
• Low protein diet management is welfare-appropriate for hepatic encephalopathy prevention.
• Ascites from portal hypertension requires welfare management with spironolactone and furosemide.
• Welfare prognosis depends on underlying cause — early diagnosis and appropriate management significantly improves outcomes.